Financhill
Back

United Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.

United Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 311.23 Buy
20-day SMA: 311.53 Buy
50-day SMA: 337.65 Sell
200-day SMA: 346.13 Sell
8-day EMA: 310.59 Buy
20-day EMA: 315.8 Sell
50-day EMA: 330.92 Sell
200-day EMA: 331.96 Sell

United Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.42 Sell
Relative Strength Index (14 RSI): 44.25 Sell
Chaikin Money Flow: 357508 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (306.83 - 318.05) Sell
Bollinger Bands (100): (327.38 - 380.72) Sell

United Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for United Therapeutics Stock

Is United Therapeutics Stock a Buy?

UTHR Technical Analysis vs Fundamental Analysis

Buy
55
United Therapeutics (UTHR) is a Buy

Is United Therapeutics a Buy or a Sell?

United Therapeutics Stock Info

Market Cap:
14B
Price in USD:
312.26
Share Volume:
461K

United Therapeutics 52-Week Range

52-Week High:
417.82
52-Week Low:
227.75
Buy
55
United Therapeutics (UTHR) is a Buy

United Therapeutics Share Price Forecast

Is United Therapeutics Stock a Buy?

  • United Therapeutics share price is 312.26 while UTHR 8-day exponential moving average is 310.59, which is a Buy signal.
  • The stock price of UTHR is 312.26 while United Therapeutics 20-day EMA is 315.80, which makes it a Sell.
  • United Therapeutics 50-day exponential moving average is 330.92 while UTHR share price is 312.26, making it a Sell technically.
  • UTHR stock price is 312.26 and United Therapeutics 200-day simple moving average is 331.96, creating a Sell signal.

Fundamental Analysis of United Therapeutics

Is United Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.81 per share, an increase this year of $2.65 per share, and an increase next year of $0.19 per share.

Technical Analysis of United Therapeutics

Should I short United Therapeutics stock?

* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.